Академический Документы
Профессиональный Документы
Культура Документы
Hardyanto Soebono
Fakultas Kedokteran UGM
AUTOIMMUNITY
Ability of immune system to differentiate
between self and non-self antigens
Immune system response against self
antigens
Autoimmune responses include antibodies
and T cells with specificity for self antigens
AUTOIMMUNITY
Autoimmunity appears normal part of
immune system
Healthy people have low concentration
of autoantibodies in serum and tissue
Auto-antibodies may form antigenantibody complex removed by
macrophages as part of tissue
damage removal
Autoimmune Disease
Autoimmune disease occurs as a result of
breakdown in tolerance to self
Autoimmune disease is characterized by immune
system attack against self antigens that lead
to tissue damage
Inflammation and hypersensitivity reactions
Mediated by B-lymphocytes that produce
antibodies to self antigens
And / or
T-lymphocytes with T-cell receptors that
recognize self antigens
Autoreactive CD4 Th and autoreactive CD8
cytotoxic T cells
Others
Psoriasis
Vitiligo
Alopecia areata
Chronic urticaria
Etc.
Autoantigen
Clinical manifestations
Pemphigus
Desmoglein-1
Desmoglein-3
Intraepidermal blisters
Bullous Pemphigoid
BPAG-1(230 kD)
BPAG-2 (180 kD)
Subepidermal blisters
Subepidermal blisters
Psoriasis
Epidermal
Hyperproliferation
Vitiligo
Melanocytes
Depigmentation
Alopecia areata
Hair follicle
Patchy baldness
SLE
Multiorgans involvement
PEMPHIGUS
A group of disorders with loss of intraepidermal adhesion
Cause: autoantibodies directed against
proteins of desmosomal complex that hold
keratinocytes together.
Classification:
Pemphigus vulgaris
Pemphigus foliaceus
Pemphigus erythematosus
Pemphigus vegetans
Pemphigus vulgaris
severe and potentially fatal autoimmune
blistering disorder affecting the skin and
mucous membranes caused by
autoantibodies against desmogleins.
Incidence : 0.1-0.5/100,000 population/yr
Pathogenesis:
Genetic predisposition: HLA-DRQ402, -DQ0505
Autoantibodies against desmoglein 3 (Dsg3), and
desmoglein 1(Dsg1)
The bound antibodies activate proteases that
damage the desmosome acantholysis
Serum Ab titer correlates with severity of disease
and course
Skin biology
Clinical pictures
Predilection : scalp, face, intertriginous
areas, mechancal stressed areas, nail
fold, oral mucosa
The blisters are not stable, as he
epidermis falls apart --> erosion &
crusts
3 stages:
Oral involvement -- 70 %
Localized areas (e.g. scalp)
Generalized disease
Diagnosis
Clinical pictures
Nikolsky sign :
Gentle rubbing results in development of
new blisters
Asboe-Hansen sign :
Pressure at edge of blister makes it spread
Histology
Immunofluorescence
Differential diagnosis
Skin lesions:
Erytema multiforme/ Stevens Johnson
Syndrome
Bullous impetigo
Hailey-Hailey disease
Oral lesions:
Erosive candidiasis
Chronic recurrent aphthae
Herpetic gingivo-stomatitis
Management
Systemic :
Corticosteroids (1-2 mg/kg/day)
Cyclophosphamide (7.5-10 mg/kg/day)
Cycloporine (5.0-7.5 mg/kg/day
Azathioprine (2.5 mgkg/day)
Topical:
Antiseptic and anticandidal
Oral anesthetic gel
Pemphigus foliaceus
Represent 10 20 % all pemphigus
Recurrent crops of vesicles/blisters easily rupture,
leaving crusted erosion
Predilection: head, neck, upper trunk, and rarely
mucous membrane
Mostly affect adult usually midlife
Nikolsky sign positive
Histopathology :
Superficial blisters with split in the granular layer
or directlt beneath the stratum corneum
Bullous Pemphigoid
Subepidermal blistering disease caused by
autoantibodies against components of the
hemidesmosomes in the basement
membrane zone (BMZ) (i.e. BPAG1/BP230
and BPAG2/BP180)
Incidence:
Most frequent autoimmune bullous
disease, affects more elder people (50-60
yrs)
Men more common affected
HD
LL
MB
MB
LD
AF
Bullous Pemphigoid
Clinical pictures:
Initialized by pruritus, urticarial lesions
then followed by development of blisters
The blisters are stable and tense as the
roof are entire epidermis, contain fluid
serum
Oralmucosa involvement <20%
Nikolsky sign negative
Bullous Pemphigoid
Histology:
Subepidermal blisters containing
eosinophils
Lamina lucida remains on the roof,and
lamina densa on the floor
Immunofluorescence:
Band of IgG and C3 along BMZ
Management
Systemic:
Prednisolone 1 mg/kg daily --> tappered
to maintenance dose 8 mg/day
Sparing agents :
Azathioprine, mycophenolate mofetil
Topical;
High potent corticosteroids
Antiseptics (Povidone iodine)
Psoriasis
Psoriasis is a chronic, inflammatory, immune-mediated
skin disease affecting ~2% of the European population1
1. Gudjonsson JE, Elder JT. Clin Dermatol. 2007;25(6):535-46. 2. Griffiths CE, Barker JN. Lancet. 2007;370:263-71. 3. Nickoloff BJ,
Nestle FO. J Clin Invest. 2004; 113:1664-75.
Bar = 200 m
Vitiligo
Alopecia areata
Circumscripta
Totalis
Universalis
Nuclear antigens:
ssDNA, dsDNA,
histon (H1, H2A, H2B, H3, H4), Sm, RNP,
Cytoplasmic antigens:
on
endothelial cells,
lymphocytes and platelets
erythrocytes,
Other antigens:
neutrophil
cells,
1. Butterfly rush
2. Discoid lupus
3. Photosensitivity
4. Oral ulceration
5. Polyarthritis
6. Nephritis
a. proteinuria over 0.5g/day
b. cellular casts
7. Pleuritis/pericarditis
8. Neuropsychiatric symptoms
a. convulsions
b. psychosis
9. Haematological alterations
a. haemolytic anaemia
b. leucopenia (4.0 G/l)
c. lymphopenia (1.5G/l)
d. thrombocytopenia (100G/l)
10. Immunologic alterations
a. anti-dsDNA
b. anti-Sm
c. anti-CL and/or LA
11. ANA
M Hochberg, 1997
4 or more symptoms are required for the diagnosis
Lupus non-specific
Chronic Cutaneous:Discoid
Note Scarring, Hyperpigmentation